ctrl K

Watchlist Price Alert

CTI BioPharma Corp. (CTIC)

NASDAQ: CTIC · Real-Time Price · USD

9.10

0.01 (0.11%)

At close: Jun 23, 2023, 7:58 PM

CTI BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	53.95M	n/a	n/a	3.35M	26.29M	25.15M	57.41M
Cost of Revenue	3.51M	161K	4.2M	n/a	879K	364K	1.38M
Gross Profit	50.43M	-161K	-4.2M	3.35M	25.41M	24.78M	56.03M
Operating Income	-79.8M	-95.33M	-47.77M	-40.71M	-32.9M	-39.52M	-49.16M
Interest Income	1.68M	38K	204K	1.17M	1.22M	n/a	-2.61M
Pretax Income	-92.99M	-97.91M	-52.45M	-40.02M	-29.35M	-40.83M	-52.95M
Net Income	-91.04M	-99.64M	-52.95M	-42.32M	-29.32M	-40.67M	-52.01M
Selling & General & Admin	84.83M	56.2M	17.63M	19.16M	21.18M	31.43M	45.31M
Research & Development	36.9M	39.14M	25.94M	24.11M	36.47M	32.87M	64.96M
Other Expenses	8.51M	-161K	4.2M	1.32M	n/a	n/a	-5.08M
Operating Expenses	130.23M	95.33M	47.77M	43.26M	57.65M	64.3M	105.19M
Interest Expense	13.14M	2.42M	1.03M	1.52M	1.73M	2.04M	2.83M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	133.75M	95.33M	47.77M	43.26M	58.53M	64.67M	106.57M
Income Tax Expense	-1.95M	1.73M	500K	2.29M	5.28M	723K	-963K
Shares Outstanding (Basic)	114.69M	90.12M	71.14M	57.97M	56.07M	36.45M	27.95M
Shares Outstanding (Diluted)	114.69M	90.12M	71.14M	57.97M	56.07M	36.45M	27.95M
EPS (Basic)	-0.79	-1.11	-0.74	-0.73	-0.52	-1.12	-1.86
EPS (Diluted)	-0.79	-1.11	-0.74	-0.73	-0.52	-1.12	-1.86
EBITDA	-79.85M	-95.33M	-47.77M	-37.42M	-32.9M	-39.52M	-49.16M
EBIT	-79.85M	-95.49M	-51.42M	-38.5M	-27.62M	-38.8M	-50.13M
Depreciation & Amortization	-56K	-161K	204K	3.29M	593K	717K	831K